Pharmacia and Upjohn Company LLC (manufacturing (formulation, aseptic filling, lyophilization), primary and secondary packaging, labeling, batch release)

The drug is recommended for the treatment of patients aged 4 years and older with a confirmed diagnosis of type 1 Gaucher disease.

Dosage form: powder, lyophilized for infusion solution

ATC: A16AB11